Chemical Compound
(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2hpyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-10-(hydroxyimino)-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one
CAS Registry Number
13127-18-9
Primary record
(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2hpyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-10-(hydroxyimino)-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one
- 库存
- 2,705 克
- 纯度
- 99.4 %
- CAS
- 13127-18-9
化合物标识与属性
- CAS
- 13127-18-9
- PubChem CID
- 57347513
- SMILES
- CC[C@@H]1[C@@]([C@@H]([C@H](C(=NO)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O
- Canonical SMILES
- CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=NO)[C@H](C)[C@@H](O)[C@]1(C)O
名称与同义词
- Erythromycin oxime
- Erythromycin-9-oxime
- Erythromycinoxime
- Erythromycin A oxime
- Erythromycin, 9-oxime
- erythromycin a 9-oxime
- Roxithromycin Impurity C
- 9-Erythromycin 9-Oxime
- RefChem:137793
- 10W452CMTZ
- 9-Hydroxyiminoerythromycin
- UNII-10W452CMTZ
- Roxithromycin EP Impurity C
- (9E)-Erythromycin A Oxime
- 13127-18-9
- Clarithromycin EP impurity J
- DTXSID201010228
- C37H68N2O13
- ERYTHROMYCIN OXIME [WHO-DD]
- BBF-04633
- MFCD08062410
- ZINC242548011
- ACN-049989
- C37-H68-N2-O13
- CS-O-11800
- MSK176984-100M
- RU-28111
- EC 603-467-4
- Erythromycin A 9-Oxime (Mixture of Z and E Isomers)
- A806231
- Erythromycin A oxime Solution in Methanol, 100ug/mL
- Q27251164
- (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2hpyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-10-(hydroxyimino)-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one
- 134931-01-4
- (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-10-(hydroxyimino)-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecan-2-one
- (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2Hpyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-10-(hydroxyimino)-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one
- (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-(hydroxyimino)-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one
- (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-10-(hydroxyimino)-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecan-2-one
- 111321-02-9
- 6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-10-hydroxyimino-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one
- 603-467-4
- Erythromycin A 9-(E)-oxime; Erythromycin 9-(E)-oxime; Oxacyclotetradecane, erythromycin deriv.; (9E)-Erythromycin A oxime; (E)-Erythromycin A oxime; (E)-Erythromycin oxime; Clarithromycin Imp. J (EP)